Genetic variation at a single nucleotide polymorphism (SNP) in the mu-opioid receptor gene (OPRM1) of both humans and rhesus macaques Macaca mulatta has been associated with differential affinity to the endogenous ligand beta-endorphin as well as alterations in pain sensitivity, drug and alcohol dependence, and social behaviors. The new study by Higham et al. (2011) presented in the current issue of this journal shows for the first time that some of the natural variation in maternal behavior observed in rhesus macaque populations can also be explained by genetic differences at this SNP. This work, in conjunction with other recent studies showing that genetic variability at this same locus are related to changes in infant attachment, provides unique insights into how opioids have been reutilized during evolution to coordinate the mother-infant relationship.
Successful development in primates is dependent upon a strong and stable attachment being formed between an infant and its caregivers, which for Old World monkeys is typically the mother. It has recently been reported that variation in infant attachment behaviors in rhesus macaques Macaca mulatta is attributable to genetic variation at the mu-opioid receptor gene (OPRM1) (Barr et al., 2008) . Now in the current issue of this journal, it is being demonstrated that this same genetic variation can explain some of the phenotypic variance observed in maternal behavior (Higham et al., 2011) . This finding has important implications for our understanding of how infant and maternal behaviors have been coadapted during evolution. In this commentary, I shall discuss the background behavioral and pharmacological evidence from sheep and primates that shows a functional role for opioids acting at mu-opioid receptors in regulating both infant attachment and maternal care. I shall then describe how these new studies, which take advantage of the natural variation in the OPRM1 gene, are providing novel insights into the neuroendocrinology of mother-infant attachment. Finally, I shall comment as to how these studies further our understanding of the evolutionary processes that have shaped mammalian mother-infant and social relationships as well as the implication of these findings for human mother-infant attachment.
Genetic Variance in OPRM1
The OPRM1 gene encodes for the G protein-coupled mu-opioid receptor that is the major site of action for endogenous opioids (particularly beta-endorphin) and exogenous opioid drugs such as morphine. Like other opioid receptors, mu-opioid receptors are widely distributed throughout the brain, though they are particularly abundant in the cingulate cortex, thalamus, periaqueductal gray, caudate putamen, nucleus accumbens, amygdala, and hippocampus (Arvidsson et al., 1995; Thompson, Mansour, Akil, & Watson, 1993) . Pharmacological studies using mu-opioid receptor agonists (e.g., morphine) and antagonists (e.g., naloxone, naltrexone) have determined that the activity of opioids at the mu-opioid receptor is central to the processing of pain (Fields, 2004) , reward in the context of drug dependence (Herz, 1997; Simmons & Self, 2009) , and social behaviors (Nelson & Panksepp, 1998 ).
In humans, over 100 SNPs are known to exist in the OPRM1 gene. Among these, one SNP located in the first exon has most frequently been identified as being functionally relevant in association studies. The nonsynonymous substitution of a guanine (G) for an adenine (A) at the 118th nucleotide position (A118G) results in an amino acid substitution (aspartic acid for asparagine) in the N terminal extracellular arm of the receptor protein (Bond et al., 1998) . This change is believed to be associated with an enhanced affinity for beta-endorphin, although the exact nature of the physiological changes conferred by this SNP has yet to be elucidated (Kroslak et al., 2007; Zhang, Wang, Johnson, Papp, & Sadee, 2005) . Significantly, individuals who are G allele carriers have been reported to have enhanced pain tolerance (Sia et al., 2008) and to be more sensitive to the euphoric effects of alcohol, more likely to abuse alcohol (Ray & Hutchison, 2004) , and more likely to respond to treatment with naltrexone for alcoholism (Oslin et al., 2003; Ray & Hutchison, 2007) .
A proposed gain-of-function OPRM1 gene variant has also been identified in the rhesus macaque. The C77G SNP similarly results in a nonsynonymous amino acid substitution (arginine for proline) in the N-terminal arm of the receptor and has been associated with increased risk of alcohol consumption, heightened aggression, and altered stress reactivity (Barr et al., 2010; Barr et al., 2007; Miller et al., 2004) . Genetic variation at the OPRM1 gene has also been reported to be associated with behavioral variation in infant attachment in rhesus macaques Macaca mulatta (Barr et al., 2008 ). In the current issue, Higham et al. (2011) demonstrate the association of this same genetic variation with maternal behavior in rhesus macaques Macaca mulatta, suggesting a possible coadaptation of this gene in the context of the motherinfant relationship. However, before considering the evolution of this gene and its functional consequences, it is necessary to put these findings within the context of previous studies on the function of the mu-opioid system in infant attachment and nurturing behaviors.
Opioids: Promoting Infant Attachment
Opioids have been implicated in promoting caregiver-directed infant behaviors that help maintain maternal care in rodents and determine the quality of mother-infant attachment in species with selective bonds (attachments) such as sheep or primates. It has been argued that the presence of the mother, who provides warmth, tactile stimulation, nurturance, and a stable base from which to explore the environment, is necessary to stimulate release of endogenous opioids in offspring that then act on the mu-opioid receptor to ensure that infants are calm and content and that the attachment bond is reinforced (Nelson & Panksepp, 1998; Weller & Feldman, 2003) . In the absence of maternal stimulation, there is a situation akin to opiate withdrawal that leads to the activation of attachment-seeking behaviors in infants such as distress vocalizations or solicitations for physical contact toward the caregiver.
In sheep, mothers and their young rapidly form a selective attachment to one another, with newborn lambs showing a significant preference for their own mother within two days provided that they are able to suckle from her (Nowak et al., 1997) . However, lambs given naltrexone immediately postbirth do not establish this selective preference for their mother and show a heightened state of social need as exemplified by shorter latencies to initiate suckling and maternal contact and emitting more highpitched bleats (Shayit, Nowak, Keller, & Weller, 2003) . Similarly, infant rhesus macaques Macaca mulatta administered mu-opioid receptor antagonists demonstrate enhanced levels of attachment behaviors. Those given naloxone initiate more social contact with their mothers, and, at the same time, increase their levels of distress vocalizations and suckling attempts (Martel, Nevison, Simpson, & Keverne, 1995) . Juvenile rhesus given the same antagonist generally seek out close physical contact by increasing grooming solicitations (Schino & Troisi, 1992) . In another set of studies, rhesus macaque infants treated with either naloxone or naltrexone similarly increased time spent clinging to their mothers and the number and intensity of distress cries following a brief separation, whereas those given morphine decreased their maternal contact and vocalizations (Kalin, Shelton, & Barksdale, 1988; Kalin, Shelton, & Lynn, 1995) . Therefore, there appears to be generally good support in large-brained precocial animals such as sheep and primates that young do increase social attachment behavior toward their mothers when opioid levels are low and mu-opioid receptors are blocked.
Interestingly, previous work in rhesus macaques Macaca mulatta has also established that genetic variation in the efficiency of the mu-opioid receptor can also lead to individual differences in attachment-seeking behavior of infants (Barr et al., 2008) . Behavioral data collected from nearly 100 individuals found that infants carrying at least one G allele showed increased levels of attachment behaviors compared to infants who were homozygous C/C. This occurred between the 18th and 24th weeks of life, a period of time just prior to weaning when infants are beginning to use the mother as a secure base to safely explore the external environment. Genotype was not found to influence any other behavioral dimensions such as assertiveness or gregariousness. At six months of age, the infants underwent four repetitions of a separation-reunion test whereby infants were removed from their mothers for four days before being reunited with their mothers for three days. With each subsequent separation trial it was found that G allele carrying infants continually increased their levels of distress vocalizations, whereas C/C infants decreased these cries. Successive reunions were also associated with an increase in the amount of time that G carrying infants spent in contact with their mother on reunion; by contrast, C/C infants did not show any change. This pattern of increased contact with mother at reunion along with elevated distress at being separated from the mother exhibited by G carrying infants is highly characteristic of the insecure-resistant type attachment shown by human preschoolers in the Ainsworth strange-situation task (Benoit, 2004) . Conversely, the C/C infants appear to have a more consistent relationship with their mothers and more appropriately use their mothers as a secure base.
Opioids and Maternal Care
The establishment, maintenance, and expression of maternal care in mammals is dependent on several hormones and neuropeptides, including estrogen, oxytocin (OT), vasopressin, and dopamine (Numan & Woodside, 2010) . Opioids are also known to be important regulators of maternal behavior in species that form specific attachments to individual offspring via synchronizing the onset of maternal behavior with parturition and maternal affect (Keverne, Nevison, & Martel, 1997) . In ewes, transcription of the proopiomelanocortin gene (which encodes the precursor protein of beta-endorphin) is upregulated by gonadal steroids during pregnancy and parturition (Broad, Kendrick, Sirinathsinghji, & Keverne, 1993) . This increase may occur in anticipation of the onset of maternal behavior and serve to alter pain sensitivity and perception in the female at the time of parturition. Evidence for a role of opioids in regulating sheep maternal care comes most strongly from studies of ICV administration of morphine accompanied by vagino-cervical stimulation (VCS, which mimics parturition) in nonparturient experienced mothers. This treatment/experience leads to an increase in maternal acceptance behaviors (e.g., licking, low-pitched bleats) and in the central release of OT (Keverne & Kendrick, 1991) . Conversely, treatment with naltrexone inhibits VCS induced release of OT and reduces the frequency of licking and low-pitched bleats by the mother and therefore the onset of attachment with her offspring (Caba et al., 1995; Kendrick & Keverne, 1989) .
Although the reproductive changes in endogenous opioid levels and mu-opioid receptor expression are not well characterized in primates, it appears they share a similar pattern to sheep as plasma beta-endorphin levels do rise during pregnancy in humans and are highest at parturition (Hoffman, Abboud, Haase, Hung, & Goebelsmann, 1984) . Continued release of beta-endorphin, at least in the periphery, is stimulated by suckling during lactation in women (Franceschini et al., 1989) and possibly also macaques (Gordon, Hodgen, & Richardson, 1992) . Moreover, multiparous rhesus macaques living in large social groups neglect their infants and do not retrieve them if there are treated with naloxone postpartum (Martel, Nevison, Rayment, Simpson, & Keverne, 1993; Martel et al., 1995) . By eight weeks of age, when females will typically have formed a grooming relationship with their infants and become very protective of them, those whose opioid receptors are blocked fail to groom their infant, though other aspects of maternal care are unaltered. Thus, the normal selective mother-infant attachment relationship is not established and indeed most mother-infant contact is infant-rather than mother-initiated.
The findings of some other studies are not consistent with the hypothesis that blocking opioid receptors disrupts primate maternal care. In a cohort of rhesus macaques Macaca mulatta with a previous history of being abusive toward their infants, naltrexone treatment during the first four weeks of life did not alter any measure of maternal behavior, though these females did solicit increased social grooming from other group members (Graves, Wallen, & Maestripieri, 2002) . Furthermore, rhesus mothers given morphine prior to being reunited with their infants showed reduced clinging behavior toward their offspring immediately postreunion, whereas when the mothers were given naltrexone they actually showed an increase in this behavior (Kalin et al., 1995) . Longtailed macaque mothers who are removed from their infants and injected with heroin (whose metabolites in the brain are mu-opioid receptor agonists) also show diminished physical contact toward their young and attenuated responsiveness to their distress calls on reunion (Misiti, Turillazzi, Zapponi, & Loizzo, 1991) . A simple explanation for the variability in findings between these pharmacological studies is that they are due to methodological differences such as the doses used, the timing of administration, and/or the specific agonists and antagonists used. They also likely represent subtle differences in the activation and suppression of mu-opioid receptors under competing social situations; some studies involve monkeys living in large social groups with mothers freely interacting with their infants whereas others focus on mother-infants dyads undergoing experimental separations and reunions.
Alternatively, perhaps background genetic factors may be responsible for these differential findings. Indeed, previous studies have demonstrated an interaction between genotype and the behavioral effects of mu-opioid agonists and antagonists. For instance, G allele carrying rhesus macaques Macaca mulatta show a higher alcohol preference than C/C individuals, however, when given naltrexone the G carriers reduce their preference whereas the C/C individuals show an increased preference (Barr et al., 2010) . Moreover, work by the group of Dario Maestripieri (2003) using a cross-fostering approach has also shown that there is some heritable genetic component to maternal behavior in rhesus macaques Macaca mulatta with polymorphic variation at the serotonin transporter being associated with variation in abusive mothering (McCormack, Newman, Higley, Maestripieri, & Sanchez, 2009 ).
Hence, given previous findings that the C77G allelic variant explained some of the observable variation in infant attachment and the pharmacological evidence that the mu-opioid receptor is involved in regulating primate maternal care, Higham et al. sought to investigate whether this variant may also influence mothering in rhesus macaques Macaca mulatta.
This study investigated rhesus macaques Macaca mulatta living on Cayo Santiago, an island off Puerto Rico that is host to approximately 1,000 individuals living in 6 large social groups. Behavioral observations of 30 females with infants from four of these groups were conducted at least one hr per week for nine months. Intriguingly, it was found that maternal OPRM1 genotype significantly predicted maternal restraining of infants even after controlling for various factors such as infant's age and female's reproductive state. Those females that were G allele carriers were found to restrain their infants 3.5 times more per hour than females that were homozygous C/C. The effect of maternal genotype was specific to this behavior as it did not significantly predict any other aspect of maternal behavior. At one time point during the study females were trapped and CSF sampled for OT (this included at least two females who did not have infants of their own during the behavioral observation period). As the trapping was only conducted at one time point during the year, the females were in different reproductive states-20 females were lactating and 12 were determined to be neither pregnant nor lactating (NPNL). Among lactating females, G carriers were found to have significantly higher CSF OT levels than homozygous C/C females. Conversely, among NPNL females, G carriers had significantly lower CSF OT levels than C/C females.
Given this finding, it is possible that one mechanism through which genetic variation in OPRM1 is exerting its influence on maternal behavior may be via the actions of opioids in the hypothalamus on central OT synthesis and secretion (Vuong, Van Uum, O'Dell, Lutfy, & Friedman, 2010) . Typically, mu-opioid receptor activation is thought to inhibit OT release, though this appears to differ according to reproductive state. For instance, the administration of morphine during late pregnancy has no effect on human maternal plasma OT levels, whereas if given during labor it significantly inhibits OT and if given postdelivery can prevent the typical rise in OT levels found in breast-feeding mothers (Lindow, Hendricks, Nugent, Dunne, & van der Spuy, 1999; Lindow, van der Spuy, Hendricks, Nugent, & Dunne, 1993; Lindow et al., 1992) . However, it may be the case that the increased affinity for endogenous opioids at the mu-opioid receptor possessed by G carrier females facilitates aspects of maternal care via stimulating OT release as appears to the case in experienced ewes given morphine at parturition (Keverne & Kendrick, 1991) . Nevertheless, such an interaction between mu-opioid receptor genotype, OT, and maternal behavior will have to remain speculative as this study did not find a correlation between CSF OT levels and any behavioral measure.
Evolution of the Role of OPRM1 in Regulating Mammalian Relationships
Although the original function of opioids may have been to regulate physiological processes such as analgesia and reward, during evolution they have gained the additional role of mediating both infant attachment and maternal care (Keverne et al., 1997) . It is particularly relevant therefore that genetic variation at the OPRM1 gene appears to predict the behavior of both mothers and infants of rhesus macaques Macaca mulatta, with those G carriers who show most distress at being separated as infants also being those who show most reluctance for their own infants to be separated from them (Barr et al., 2008; Higham et al., 2011) . This is similar to findings in mice that have shown that the same gene can promote both the ability of offspring to extract care from their mother as well as the ability of females to provide this care (Curley, Barton, Surani, & Keverne, 2004) . Having the same gene variant regulating both infant and mother attachment is an example of coadaptive evolution whereby both successful infant development and mothering is ensured (Keverne & Curley, 2008) .
It has also been proposed that complex social relationships such as those found in primates that are characterized by multiple attachments to specific adult individuals have reutilized these same neuroendocrine mechanisms that evolved initially to promote mother-infant attachment (Broad, Curley, & Keverne, 2006; Curley & Keverne, 2005) . As these social relationships are no longer restricted to hormonal events associated with sex or parturition, it is proposed that the rewarding actions of opioids released during, for example, social grooming, were specifically coopted for this purpose (Keverne, Martensz, & Tuite, 1989) . It is therefore extremely interesting that two further recent studies have reported that variation at the OPRM1 gene is associated with variation in human social behavior including the quality of adult attachments. First, G carriers of the human OPRM1 gene are more likely to become engaged in affiliative relationships (they score lower on measures of avoidant attachment) and report feeling more pleasure from social situations (they score lower on measures of social anhedonia) (Troisi et al., 2010) . In another study, G carriers also show greater sensitivity to social rejection as well as greater activation of areas of the brain known to process physical and social pain, such as the dorsal anterior cingulate cortex and anterior insula (Way, Taylor, & Eisenberger, 2009) . Taken together with studies of rhesus macaques Macaca mulatta, there appears to be good support for the hypothesis that activation of the opioid system underlies the evolution of both mother-infant and social attachments and this is in part mediated by changes in OPRM1.
Furthermore, there appears to be converging evidence from studies of both humans and rhesus macaques Macaca mulatta that across primates G allele carriers are more likely to show a need to engage in affiliative relationships, are more rewarded by doing so, and are more sensitive to social rejection. An interesting evolutionary question is why this genotypic variation has been maintained during evolution. We currently do not have an answer, though it could possibly be due to frequency-dependent selection processes with different allelic copies being advantageous at differing frequencies or in particular environments (Way & Lieberman, 2010) . Intriguingly, one recent study has identified that the human A118G SNP has undergone recent positive selection in the human lineage (Pang, Wang, Wang, Goh, & Lee, 2009) . Although the mu-opioid receptor has a role in the functioning of many behaviors, perhaps evolutionary modifications to OPRM1 in modern humans enabled those changes in mother-infant and social bonding that are thought to have facilitated our large brains (Dunbar, 2010) .
What About Human Mother-Infant Attachment?
The findings from Higham et al. (2011) also raise questions regarding the relevance to human maternal care. Although one must obviously be wary in overgeneralizing the results of animal studies, converging evidence suggests that genetic variation at OPRM1 could potentially underlie variation in human mothering. First, it is clear that opioids do play a role in human mother-infant attachment. Data from mothers enrolled in methadone programs indicate that these mothers are less likely to remain their child's primary parent and are more likely to be reported for abuse or abandonment of their child when compared to controls matched for other sociodemographic factors (Lejeune et al., 1997) . Pregnant women enrolled in these programs also report worse scores of attachment to their unborn child than controls (Goodman, Hans, & Cox, 1999; Mikhail, Youchah, DeVore, Ho, & Anyaegbunam, 1995) . Second, as in rhesus macaques Macaca mulatta, phenotypic variation in human maternal behavior has been shown to be partially heritable (Neiderhiser et al., 2004 ) and molecular studies have begun to report associations between parenting and genetic variation in genes encoding proteins known to be involved in the regulation of mammalian maternal care such as monoamines and OT. For instance, differences in maternal sensitivity are predicted by polymorphisms of the serotonin transporter and OT receptor genes MilevaSeitz et al., 2011) as well as by an interaction between stressful life events and polymorphisms of the dopamine receptor or catechol-O-methyl transferase genes (van Ijzendoorn, BakermansKranenburg, & Mesman, 2008) . Likewise, interactions between the perceived care experienced by mothers during their own upbringing and polymorphisms of the serotonin transporter gene have been shown to be associated with both attachment scores and the frequency of interaction of mothers toward their own infants (Mileva-Seitz et al., 2011) . It will be interesting to see in future studies whether OPRM1 genotype does indeed explain a small yet significant degree of variation in human mothering, either directly or when considered in association with other life experiences.
In conclusion, the study by Higham et al. is further evidence for a role of opioids in regulating mother-infant attachment via their activation of the mu-opioid receptor and suggests that individual differences in parenting are to some extent related to heritable differences in the OPRM1 gene sequence. In addition, this study also demonstrates that behavioral research of primates in natural populations combined with modern molecular genetics approaches can provide us with invaluable and unique insights into the evolution of the neuroendocrine basis of affiliative relationships of all primates including ourselves.
